Exhibit 99.1 CVRx Reports Second Quarter 2025 Financial and Operating Results MINNEAPOLIS, August 4, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the second quarter of 2025. Recent Highlights "We delivered solid second quarter results and continued to build mom ...